ArticleJournal of medicinal chemistry2012

Structure-activity relationship (SAR) study of ethyl 2-amino-6-(3,5-dimethoxyphenyl)-4-(2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate (CXL017) and the potential of the lead against multidrug resistance in cancer treatment.

Gopalakrishnan Aridoss et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.